Hochschulschrift
Evaluation of D-TMPP for use in diagnosis and specific cellular immunotherapy of prostate cancer
- Sprache
-
Englisch
- Umfang
-
127 Bl.
- Maße
-
30 cm
- Anmerkungen
-
Ill., graph. Darst.
Dresden, Techn. Univ., Diss., 2007
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Conceição Cunha, Ana Margarida da
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.03.2025, 11:59 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Conceição Cunha, Ana Margarida da
Ähnliche Objekte (12)
Immunotherapy of Prostate Carcinoma with biodegradable PLGA Microspheres
Cellular mechanisms of antigen-specific immunotherapy of autoimmune disease
Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer
Development and Characterization of a novel Immunotherapy against Prostate Cancer
Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma
Cellular immunotherapy of pancreatic ductal adenocarcinoma: Discovery and evaluation of novel target candidates
Cellular immunotherapy in patients with advanced Ewing sarcoma
CpG-DNA – a potential adjuvant in prostate cancer immunotherapy
CpG-DNA : a potential adjuvant in prostate cancer immunotherapy
Diagnosis of clinically significant prostate cancer diagnosis without histological proof in the prostate-specific membrane antigen era: the jury is still out
Identification of naturally presented immunogenic HLA ligands of prostate cancer and HCMV-infected cells for immunotherapy
PSMA inhibitor-based radiopharmaceuticals for diagnosis and therapy of prostate cancer
Immunotherapy of Prostate Carcinoma with biodegradable PLGA Microspheres
Cellular mechanisms of antigen-specific immunotherapy of autoimmune disease
Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer
Development and Characterization of a novel Immunotherapy against Prostate Cancer
Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma
Cellular immunotherapy of pancreatic ductal adenocarcinoma: Discovery and evaluation of novel target candidates
Cellular immunotherapy in patients with advanced Ewing sarcoma
CpG-DNA – a potential adjuvant in prostate cancer immunotherapy
CpG-DNA : a potential adjuvant in prostate cancer immunotherapy
Diagnosis of clinically significant prostate cancer diagnosis without histological proof in the prostate-specific membrane antigen era: the jury is still out
Identification of naturally presented immunogenic HLA ligands of prostate cancer and HCMV-infected cells for immunotherapy
PSMA inhibitor-based radiopharmaceuticals for diagnosis and therapy of prostate cancer
Immunotherapy of Prostate Carcinoma with biodegradable PLGA Microspheres
Cellular mechanisms of antigen-specific immunotherapy of autoimmune disease
Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer
Development and Characterization of a novel Immunotherapy against Prostate Cancer
Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma
Cellular immunotherapy of pancreatic ductal adenocarcinoma: Discovery and evaluation of novel target candidates
Cellular immunotherapy in patients with advanced Ewing sarcoma
CpG-DNA – a potential adjuvant in prostate cancer immunotherapy
CpG-DNA : a potential adjuvant in prostate cancer immunotherapy
Diagnosis of clinically significant prostate cancer diagnosis without histological proof in the prostate-specific membrane antigen era: the jury is still out
Identification of naturally presented immunogenic HLA ligands of prostate cancer and HCMV-infected cells for immunotherapy